临床医生对急性呼吸窘迫综合征的识别对内科ICU循证干预的影响
通过电子病历关键词搜索识别临床医生记录的ARDS,其对专家裁定ARDS的敏感性47.5%、特异性91.1%、阳性预测值77.4%、阴性预测值73.1%。在381例专家裁定ARDS中,识别与未识别组潮气量无差异,但识别组累计液体平衡更负(均差-781 mL,95%CI -1846至+283)且更常使用利尿剂(49.3% vs 35.7%,P=0.02)。死亡率、ICU住院时间和无 ventilator 天数无差异。提示ARDS识别率低,识别主要影响液体管理行为而非通气策略或患者结局。
要点
- 临床医生记录识别ARDS对专家裁定ARDS的敏感性仅47.5%、特异性91.1%,阳性预测值77.4%、阴性预测值73.1%,提示床旁漏识常见。
- 在381例专家裁定ARDS中,识别组与未识别组潮气量无差异,即识别未带来更低的通气潮气量。
- 识别组累计液体平衡更负(均差-781 mL,95%CI -1846至+283),利尿剂使用更多(49.3% vs 35.7%,P=0.02)。
- 识别与未识别组在死亡率、ICU住院时间、无 ventilator 天数上均无差异。
- 该研究为单中心观察性队列,识别通过电子病历关键词搜索定义,结果不能推断因果或外推为通用推荐。
适用人群与场景
- 场景为内科ICU;原文未提及院前或急诊场景,也未列出具体纳入/排除标准。
诊断标准与关键阈值
- 专家裁定ARDS为参照标准;临床医生识别ARDS通过电子病历临床记录的关键词电子搜索确定。
- 临床医生识别ARDS对专家裁定ARDS的判别性能:敏感性47.5%、特异性91.1%、阳性预测值77.4%、阴性预测值73.1%。
- 原文未提及具体的氧合指数阈值、PEEP条件或ARDS诊断标准名称。
处置流程与药物剂量
- 原文未提及具体的通气策略、药物剂量、给药途径、频次或目标值。
- 观察到识别组更常使用利尿剂(49.3% vs 35.7%,P=0.02),累计液体平衡更负(均差-781 mL,95%CI -1846至+283),但原文未给出利尿剂名称、剂量或液体管理方案。
红旗征与不能漏的情况
- 原文未提及具体的红旗征或不能漏诊的情况及相应处理。
研究设计与关键结果
- 干预/暴露:临床医生识别ARDS(电子病历关键词搜索)vs 未识别;对照为专家裁定ARDS。
- 主要结果:识别ARDS对专家裁定ARDS敏感性47.5%、特异性91.1%、阳性预测值77.4%、阴性预测值73.1%。
- 在381例专家裁定ARDS中,潮气量无差异;识别组累计液体平衡更负(均差-781 mL,95%CI -1846至+283),利尿剂使用更多(49.3% vs 35.7%,P=0.02)。
- 死亡率、ICU住院时间、无 ventilator 天数无差异。
证据类型、等级与局限
- 证据类型:观察性队列研究(单中心)。
- 局限:单中心、观察性设计、识别依靠电子病历关键词搜索、样本来自2006至2015年、不能推断因果。
对床旁实践的改变
- 提示在内科ICU中临床医生对ARDS的识别率偏低,床旁应警惕漏识,但不能由本文推出具体筛查工具或诊断流程。
- 本文显示识别ARDS与更积极的液体负平衡和利尿剂使用相关,但未改变潮气量、死亡率、ICU住院时间或无 ventilator 天数,因此不能据此改变通气策略或结局预期。
- 适用人群为内科ICU危重成人;原文未提及急诊、院前、儿科或其他人群的适用性。
- 常见陷阱:将观察性关联误读为识别ARDS可改善结局;本文未证实识别能降低死亡率或缩短ICU住院时间。
指南或共识出处
- 原文未提及指南或共识名称;来源期刊为Crit Care Explor。
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
UNLABELLED: Acute respiratory distress syndrome is underrecognized in the ICU, but it remains uncertain if acute respiratory distress syndrome recognition affects evidence-based acute respiratory distress syndrome care in the modern era. We sought to determine the rate of clinician-recognized acute respiratory distress syndrome in an academic medical ICU and understand how clinician-recognized-acute respiratory distress syndrome affects clinical care and patient-centered outcomes.
DESIGN: Observational cohort study.
SETTING: Single medical ICU at an academic tertiary-care hospital.
PATIENTS: Nine hundred seventy-seven critically ill adults (381 with expert-adjudicated acute respiratory distress syndrome) enrolled from 2006 to 2015.
INTERVENTIONS: Clinician-recognized-acute respiratory distress syndrome was identified using an electronic keyword search of clinical notes in the electronic health record. We assessed the classification performance of clinician-recognized acute respiratory distress syndrome for identifying expert-adjudicated acute respiratory distress syndrome. We also compared differences in ventilator settings, diuretic prescriptions, and cumulative fluid balance between clinician-recognized acute respiratory distress syndrome and unrecognized acute respiratory distress syndrome.
MEASUREMENTS AND MAIN RESULTS: Overall, clinician-recognized-acute respiratory distress syndrome had a sensitivity of 47.5%, specificity 91.1%, positive predictive value 77.4%, and negative predictive value 73.1% for expert-adjudicated acute respiratory distress syndrome. Among the 381 expert-adjudicated acute respiratory distress syndrome cases, we did not observe any differences in ventilator tidal volumes between clinician-recognized-acute respiratory distress syndrome and unrecognized acute respiratory distress syndrome, but clinician-recognized-acute respiratory distress syndrome patients had a more negative cumulative fluid balance (mean difference, -781 mL; 95% CI, [-1,846 to +283]) and were more likely to receive diuretics (49.3% vs 35.7%, p = 0.02). There were no differences in mortality, ICU length of stay, or ventilator-free days.
CONCLUSIONS: Acute respiratory distress syndrome recognition was low in this single-center study. Although acute respiratory distress syndrome recognition was not associated with lower ventilator volumes, it was associated with differences in behaviors related to fluid management. These findings have implications for the design of future studies promoting evidence-based acute respiratory distress syndrome interventions in the ICU.
参考来源
- Kerchberger VE, Brown RM, Semler MW, et al. Impact of Clinician Recognition of Acute Respiratory Distress Syndrome on Evidenced-Based Interventions in the Medical ICU. Crit Care Explor. 2021. PMID: 34250497. doi:10.1097/CCE.0000000000000457
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。